- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-06-0015074

About Stereo Drugs Private Limited
Data last updated:
Stereo Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aura Research And Remedies Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2008PTC059539. Its GSTIN is 29AAMCS1010P1Z1 (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors Akkisani (Managing Director) and Prathima Arveti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.165/P Aparna Palm Groves Ground Floor, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.02 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Lakh (net margin 1.6%) and EBITDA of ₹43.75 Lakh (EBITDA margin 43%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 45% over five years.
As per MCA filings, the company has satisfied charges of ₹17.06 Cr on record. Court records list 8 cases involving the company, including 8 filed against it; 1 case is pending.
Stereo Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0015074). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stereodrugs.com.
Company details
CIN history
Stereo Drugs has one previous CIN (Corporate Identification Number): U24233AP2008PTC059539. The current CIN is U24233TG2008PTC059539, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2008PTC059539 | Current |
| U24233AP2008PTC059539 | Previous |
Recognitions & Rankings of Stereo Drugs
Contact details
Stereo Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is stereodrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.165/P Aparna Palm Groves Ground Floor, Phase – 1 Kompally Medchal Dist Telangana, Hyderabad, Telangana, India – 500100
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Stereo Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stereo Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stereo Drugs Private Limited, buy the company report.
Financials of Stereo Drugs Private Limited
FY 2025 filings availableStereo Drugs Private Limited reported revenue of ₹1.02 Cr (down 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 45% over five years, including a 45% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stereo Drugs Private Limited, buy the company report.
Board of directors of Stereo Drugs Private Limited
Stereo Drugs has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prathima Arveti Also directs: Aura Research and Remedies Private Limited | Director | 17 Aug 2023 | 3 Years 3 Months | Current |
| Akkisani | Managing Director | 01 Dec 2022 | 3 Years 11 Months | Current |
Auditor
Stereo Drugs Private Limited is audited by K.RAMBABU & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.RAMBABU & Co. | FY 2022 | 224953 |
Shareholding
The shareholding of Stereo Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stereo Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2014 | 10483075 | Axis Bank Limited | ₹5.35 Lakh | Satisfied | |
| 31 Oct 2013 | 10459599 | Axis Bank Limited | ₹11.86 Cr | Satisfied | |
| 22 Aug 2011 | 10302538 | Corporation Bank | ₹5.14 Cr | Satisfied |
To see the full charge records of Stereo Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Stereo Drugs Private Limited has 8 court cases on record: 8 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
| High courts | 2 | 2 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by M/S Shree Dulichand Chemicals Private Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by M/S. Shilpa Chemspec International Pvt. Ltd. | Disposed |
| High Court, TELANGANA | Appeal | Filed against the company by Employees State Insurance Corporation and 1 other | Pending |
| District court, BIDAR, Karnataka | Criminal complaint | Filed against the company by State Level Environment Impact Assessment Authority. | Disposed |
| High Court, TELANGANA | Company petition | Filed against the company by Shanghai Wilpower Industrial Co. Ltd., | Disposed |
To see the full case history of Stereo Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stereo Drugs Private Limited was last rated by Crisil on 27 Jul 2017.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 27 Jul 2017 |
To see the full credit ratings and regulatory alerts of Stereo Drugs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stereo Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stereo Drugs has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAMCS1010P1Z1 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stereo Drugs Private Limited, buy the company report.
Recent activity
Stereo Drugs Private Limited has 11 board changes on record since 2009: 2 appointments and 9 cessations. The latest: Akkisani ceased to be Additional Director on 31 Jan 2024.
10 earlier events are in the company report.
Frequently asked questions
Stereo Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2008 (18+ years old) and is registered under CIN U24233TG2008PTC059539.
Stereo Drugs has 2 current directors:
- Akkisani - Managing Director
- Prathima Arveti - Director
The latest financial statements of Stereo Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stereo Drugs is 29AAMCS1010P1Z1, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Stereo Drugs is U24233TG2008PTC059539. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stereo Drugs has 8 court cases on record: 8 filed against it. 1 is pending. Most are in the district courts.
Stereo Drugs was incorporated on 06 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
Akkisani ceased to be Additional Director on 31 Jan 2024. Anand Srinivas Katta ceased to be Additional Director on 22 Aug 2023. Prathima Arveti was appointed as Director on 17 Aug 2023. Stereo Drugs has 11 board changes on record in total.
Yes, Stereo Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-KR-06-0015074).
Stereo Drugs can be reached through the website stereodrugs.com. Its registered office is in Hyderabad, Telangana, India.

